• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Kpl Share Price

    Kwality Pharmaceuticals Share PriceKwality Pharmaceuticals

    Small Cap 2.8k Result
    ₹371.05
    -1.75 (-0.47%)
    As on 06 December, 2023 | 16:52 BSE: 539997 NSE: KPLISIN: INE552U01010

    Kwality Pharmaceuticals Performance

    Day Range

    • Low
    • High
    ₹ 371.05

    52 Week Range

    • Low
    • High
    ₹ 371.05
    • Open Price
    • Previous Close
    • Volume

    Start SIP in Kwality Pharmaceuticals

    Start SIP

    Kwality Pharmaceuticals Share Price

    • Over 1 Month 9.37%
    • Over 3 Month -4.03%
    • Over 6 Month 25.74%
    • Over 1 Year 12.51%

    Kwality Pharmaceuticals Key Statistics

    Kwality Pharmaceuticals Investment Rating

    • Master Rating:

    • M K Proteins has an operating revenue of Rs. 660.58 Cr. on a trailing 12-month basis. An annual revenue growth of 23% is outstanding, Pre-tax margin of 5% is okay, ROE of 21% is exceptional. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 6% and 20% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 45 which is a POOR score indicating inconsistency in earnings, a RS Rating of 51 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 136 indicates it belongs to a poor industry group of Food-Packaged and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Kwality Pharmaceuticals Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 70676956567064
    Operating Expenses Qtr Cr 54545741405248
    Operating Profit Qtr Cr 15141215161816
    Depreciation Qtr Cr 5544433
    Interest Qtr Cr 2222111
    Tax Qtr Cr 22-23244
    Net Profit Qtr Cr 65-7791110
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 254460
    Operating Expenses Annual Cr 191284
    Operating Profit Annual in Cr 60172
    Depreciation Cr 1511
    Interest Annual Cr 63
    Tax Annual Cr 642
    Net Profit Annual Cr 19120
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 4263
    Cash from Investing Activity Annual Cr -48-63
    Cash from Financing Annual Activity Cr 16
    Net Cash Flow Annual Cr -56
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 202183
    Fixed Assets Annual Cr 134103
    Total Non Current Assets Annual Cr 149115
    Total Current Assets Annual Cr 208227
    Total Assets Annual Cr 357343
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 195176
    ROE Annual % 1066
    ROCE Annual % 2177
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2538
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 70676956567064
    Operating Expenses Qtr Cr 54545741405248
    Operating Profit Qtr Cr 15141115161816
    Depreciation Qtr Cr 5544433
    Interest Qtr Cr 2222111
    Tax Qtr Cr 22-23244
    Net Profit Qtr Cr 65-7791110
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 254460
    Operating Expenses Annual Cr 191285
    Operating Profit Annual in Cr 60172
    Depreciation Cr 1511
    Interest Annual Cr 63
    Tax Annual Cr 642
    Net Profit Annual Cr 19120
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 4164
    Cash from Investing Activity Annual Cr -48-63
    Cash from Financing Annual Activity Cr 16
    Net Cash Flow Annual Cr -67
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 201181
    Fixed Assets Annual Cr 135104
    Total Non Current Assets Annual Cr 146113
    Total Current Assets Annual Cr 207228
    Total Assets Annual Cr 354341
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 192173
    ROE Annual % 1067
    ROCE Annual % 2178
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2538
    Invest in Kwality Pharmaceuticals

    Kwality Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹371.05
    -1.75 (-0.47%)
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹368.10
    • 50 Day
    • ₹360.15
    • 100 Day
    • ₹354.96
    • 200 Day
    • ₹353.20
    • 20 Day
    • ₹362.78
    • 50 Day
    • ₹354.17
    • 100 Day
    • ₹361.21
    • 200 Day
    • ₹338.49

    Kwality Pharmaceuticals Resistance and Support

    PIVOT
    ₹377.55
    Resistance
    First Resistance 385.10
    Second Resistance 397.40
    Third Resistance 404.95
    RSI 54.27
    MFI 74.46
    MACD Single Line 7.92
    MACD 9.39
    Support
    First Resistance 365.25
    Second Resistance 357.70
    Third Resistance 345.40

    Kwality Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 9,092 667,807 73.45
    Week 14,462 938,847 64.92
    1 Month 15,477 1,174,888 75.91
    6 Month 26,969 2,079,873 77.12

    Kwality Pharmaceuticals Result Highlights

    Kwality Pharmaceuticals Synopsis

    NSE-Food-Packaged

    M K Proteins belongs to the Industry of Edible Oils & Solvent Extraction. Company’s Total Operating Revenue is Rs. 314.86 Cr. and Equity Capital is Rs. 12.51 Cr. for the Year ended 31/03/2023. M K Proteins Ltd. is a Public Limited Listed company incorporated on 15/06/2012 and has its registered office in the State of Haryana, India. Company’s Corporate Identification Number(CIN) is L15500HR2012PLC046239 and registration number is 046239.
    Market Cap 1,119
    Sales 405
    Shares in Float 3.13
    No of funds 1
    Yield
    Book Value 22.09
    U/D Vol ratio 1.2
    LTDebt / Equity 5
    Alpha 0.16
    Beta -0.22

    Kwality Pharmaceuticals

    Owner NameSep-23Jun-23Mar-23Feb-23
    Promoters 74.82%74.82%74.82%74.82%
    Foreign Portfolio Investors
    Individual Investors 12.27%11.56%11.47%11.45%
    Others 12.91%13.62%13.71%13.73%

    Kwality Pharmaceuticals Management

    Name Designation
    Mr. Vinod Kumar Managing Director & CEO
    Mr. Raj Kumar Whole Time Director
    Mr. Parvind Kumar Non Executive Director
    Mr. Parmod Kumar Non Executive Director
    Mr. Chatter Singh Ind. Non-Executive Director
    Mr. Raman Kumar Sah Ind. Non-Executive Director
    Mr. Abhay Kumar Ind. Non-Executive Director
    Mr. Dinesh Singh Malik Ind. Non-Executive Director
    Ms. Laxmi Mandal Ind. Non-Executive Director

    Kwality Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Kwality Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2023-11-04 Quarterly Results
    2023-08-10 Quarterly Results
    2023-05-27 Audited Results
    2023-02-14 Quarterly Results
    2022-11-14 Quarterly Results

    Kwality Pharmaceuticals FAQs

    What is Share Price of Kwality Pharmaceuticals ?

    Kwality Pharmaceuticals share price is ₹371 As on 06 December, 2023 | 16:38

    What is the Market Cap of Kwality Pharmaceuticals ?

    The Market Cap of Kwality Pharmaceuticals is ₹385 Cr As on 06 December, 2023 | 16:38

    What is the P/E ratio of Kwality Pharmaceuticals ?

    The P/E ratio of Kwality Pharmaceuticals is 33.7 As on 06 December, 2023 | 16:38

    What is the PB ratio of Kwality Pharmaceuticals ?

    The PB ratio of Kwality Pharmaceuticals is 1.9 As on 06 December, 2023 | 16:38

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.